Washington University in St. Louis (WU)
My focus is cancer metabolism. Specifically, I am interested in integrating techniques in genomics and metabolomics to identify metabolic determinants of poor prognosis in neuroendocrine carcinomas. I will use this information to develop metabolism-directed imaging protocols with functional MRI and PET. Information obtained in concert with these strategies will be used to develop new strategies in pharmaceutical development.